Jun 5, 2026 10:00AM
Apr 8, 2026 12:14PM
Apr 1, 2026 11:50AM
Jan 13, 2026 09:00AM
Oct 30, 2025 09:01AM
Oct 30, 2025 09:00AM
Oct 8, 2025 09:00AM Validated for Global Scale: DIAGNOS Passes Annual MDSAP Audit, Solidifying the Pathway to Approvals with Health Canada & FDA
Jul 16, 2025 09:00AM
Jun 4, 2025 06:30AM
Mar 31, 2025 09:00AM
Mar 12, 2025 09:15AM
Feb 25, 2025 09:05AM
Aug 20, 2024 09:45AM
Apr 16, 2024 11:08AM DIAGNOS to expedite application for Medical Device License to Health Canada and US FDA related to its 4 new analysis modules, and is planning ISO 27001 certification
May 17, 2023 12:49PM
Feb 28, 2023 09:00AM
Feb 14, 2023 10:36AM
Feb 10, 2023 03:56PM
Jan 31, 2023 10:04AM
Oct 27, 2022 11:29AM
Sep 1, 2022 09:30AM DIAGNOS Announces Closing of Private Placement
Aug 18, 2022 12:26PM
Jul 27, 2022 09:00AM
Jun 23, 2022 09:00AM
Jun 7, 2022 11:44AM
May 26, 2022 09:58AM
May 10, 2022 10:32AM
Apr 26, 2022 09:00AM DIAGNOS Announces the Extension of its Contract with Novo Nordisk for the Follow-up of Diabetic Patients Under Treatment with Drugs Included in its Therapeutic Portfolio
Mar 28, 2022 04:15PM
Mar 15, 2022 02:00PM
Mar 1, 2022 12:54PM
Feb 10, 2022 10:14AM
Dec 15, 2021 09:00AM
Nov 23, 2021 09:00AM
Oct 28, 2021 09:00AM DIAGNOS Delivers World Class Results in the MICCAI2021 Contest: GAMMA
Sep 24, 2021 09:00AM
Sep 16, 2021 09:00AM
Sep 14, 2021 09:00AM
Sep 10, 2021 01:34PM
Sep 2, 2021 09:00AM
Aug 17, 2021 03:30PM
Aug 16, 2021 09:00AM DIAGNOS signs Memorandum of Understanding with Essilor International.
Jul 28, 2021 09:05AM
Jul 22, 2021 09:05AM
Jul 20, 2021 10:05AM
Jun 15, 2021 11:20AM
Jun 9, 2021 08:00AM

323,577 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All